Antidonor antibody in patients receiving ABO-identical and HLA-mismatched living donor liver transplants: Effect on survival

Transplantation

Volumn 83, Issue 4, 2007, Pages 506-509

  Ashihara, Eishi ^a,b   Tsuji, Hiroaki ^a   Sakashita, Hiromi ^b   Haga, Hironori ^b   Yurugi, Kimiko ^a   Kimura, Shinya ^a   Egawa, Hiroto ^b   Manabe, Toshiaki ^b   Uemoto, Shinji ^b   Maekawa, Taira ^a  

^a Department of Blood Transfusion and Cell Therapy ^*  (Japan)

^b KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Antidonor antibody; Direct lymphocyte crossmatch; Human leukocyte antigen; Living donor liver transplantation

Indexed keywords

ANTIBODY; LEUKOCYTE ANTIGEN; HLA ANTIGEN;

ADULT; ADVERSE OUTCOME; AGING; ANTIBODY PRODUCTION; ARTICLE; BLOOD GROUP ABO SYSTEM; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; GRAFT RECIPIENT; HLA MATCHING; HUMAN; LIVER TRANSPLANTATION; LIVING DONOR; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; SURVIVAL; SURVIVAL TIME; TREATMENT OUTCOME; ADOLESCENT; AGED; CHILD; IMMUNOLOGY; INFANT; MIDDLE AGED; NEWBORN; PATHOLOGY; PRESCHOOL CHILD; SURVIVAL RATE;

ABO BLOOD-GROUP SYSTEM; ADOLESCENT; ADULT; AGED; ANTIBODIES; CHILD; CHILD, PRESCHOOL; FEMALE; HLA ANTIGENS; HUMANS; INFANT; INFANT, NEWBORN; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; SURVIVAL RATE;

EID: 33947514866     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000251361.12249.a1     Document Type: Article

References (12)

1. McCloskey D, Festenstein H, Banner N, et al. The effect of HLA lymphocytotoxic antibody status and crossmatch result on cardiac transplant survival. Transplant Proc 1989; 21: 804.
2. Lazda VA, Mozes MF. An evaluation of HLA cross-reactive group matching on graft survival in deceased donor kidney recipients. Transplant Proc 2005; 372: 661.
3. Muro M, Marin L, Miras M, et al. Liver recipients harbouring antidonor preformed lymphocytotoxic antibodies exhibit a poor allograft survival at the first year after transplantation: experience of one centre. Transpl Immunol 2005; 14: 91.
4. Sugawara Y, Makuuchi M, Kaneko J, et al. Positive T lymphocytotoxic cross-match in living donor liver transplantation. Liver Transpl 2003; 9: 1062.
5. Sugawara Y, Makuuchi M, Kaneko J, et al. Risk factors for acute rejection in living donor liver transplantation. Clin Transplant 2003; 17: 347.
6. Suehiro T, Shimada M, Kishikawa K, et al. Influence of HLA compatibility and lymphocyte cross-matching on acute cellular rejection following living donor adult liver transplantation. Liver Int 2005; 25: 1182.
7. Kasahara M, Kiuchi T, Takakura K, et al. Postoperative flow cytometry crossmatch in living donor liver transplantation: clinical significance of humoral immunity in acute rejection. Transplantation 1999; 67: 568.
8. Takakura K, Kiuchi T, Kasahara M, et al. Clinical implications of flow cytometry crossmatch with T or B cells in living donor liver transplantation. Clin Transplant 2001; 15: 309.
9. Tanaka K, Uemoto S, Tokunaga Y, et al. Surgical techniques and innovations in living related liver transplantation. Ann Surg 1993; 217: 82.
10. Inomata Y, Tanaka K, Egawa H, et al. The evolution of immunosuppression with FK506 in pediatric living-related liver transplantation. Transplantation 1996; 27: 247.
11. Noreen HJ. Crossmatch tests. In: Mikaen A, Phelan DL, Mickelson, eds. ASHI laboratory manual, 3rd Ed. Lenexa KS: The American Society for Histocompatibility and Immunogenetics, 1994.
12. Nikaein A, Backman L, Jennings L, et al. HLA compatibility and liver transplant outcome. Improved patient survival by HLA and cross-matching. Transplantation 1994; 58: 786.